Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Nov;116(6):2625–2630. doi: 10.1111/j.1476-5381.1995.tb17217.x

Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.

T Kinonen 1, M Pasanen 1, J Gynther 1, A Poso 1, T Järvinen 1, E Alhava 1, R O Juvonen 1
PMCID: PMC1909112  PMID: 8590980

Abstract

1. We have shown earlier that pilocarpine strongly inhibits mouse and human liver coumarin 7-hydroxylase activity of CYP 2A and pentoxyresorufin O-deethylase activity of CYP 2B in vitro. Since pilocarpine, like coumarin, contains a lactone structure we have studied in more detail its inhibitory potency on mouse and human liver coumarin 7-hydroxylation. 2. Pilocarpine was a competitive inhibitor of coumarin 7-hydroxylase in vitro both in mouse and human liver microsomes although it was not a substrate for CYP 2A5. Ki values were similar, 0.52 +/- 0.22 microM in mice and 1.21 +/- 0.51 microM in human liver microsomes. 3. Pilocarpine induced a type II difference spectrum in mouse, human and recombinant CYP 2A5 yeast cell microsomes, with Ka values of 3.7 +/- 1.6, 1.6 +/- 1.1 and 1.5 +/- 0.1 microM, respectively. 4. Increase in pH of the incubation medium from pH 6 to 7.5 increased the potency of inhibition of coumarin 7-hydroxylation by pilocarpine. 5. Superimposition of pilocarpine and coumarin in such a way that their carbonyls, ring oxygens and the H-7' of coumarin and N-3 of pilocarpine overlap yielded a common molecular volume of 82%. 6. The results indicate that pilocarpine is a competitive inhibitor and has a high affinity for mouse CYP 2A5 and human CYP 2A6. In addition the immunotype nitrogen of pilocarpine is coordinated towards the haem iron in these P450s.

Full text

PDF
2625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitio A. A simple and sensitive assay of 7-ethoxycoumarin deethylation. Anal Biochem. 1978 Apr;85(2):488–491. doi: 10.1016/0003-2697(78)90245-2. [DOI] [PubMed] [Google Scholar]
  2. Cohen A. J. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food Cosmet Toxicol. 1979 Jun;17(3):277–289. doi: 10.1016/0015-6264(79)90289-x. [DOI] [PubMed] [Google Scholar]
  3. Egan D., O'Kennedy R., Moran E., Cox D., Prosser E., Thornes R. D. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev. 1990;22(5):503–529. doi: 10.3109/03602539008991449. [DOI] [PubMed] [Google Scholar]
  4. Gibson G. G., Tamburini P. P. Cytochrome P-450 spin state: inorganic biochemistry of haem iron ligation and functional significance. Xenobiotica. 1984 Jan-Feb;14(1-2):27–47. doi: 10.3109/00498258409151397. [DOI] [PubMed] [Google Scholar]
  5. Honkakoski P., Mäenpä J., Leikola J., Pasanen M., Juvonen R., Lang M. A., Pelkonen O., Raunio H. Cytochrome P4502A-mediated coumarin 7-hydroxylation and testosterone hydroxylation in mouse and rat lung. Pharmacol Toxicol. 1993 Feb;72(2):107–112. doi: 10.1111/j.1600-0773.1993.tb00299.x. [DOI] [PubMed] [Google Scholar]
  6. Jefcoate C. R. Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy. Methods Enzymol. 1978;52:258–279. doi: 10.1016/s0076-6879(78)52029-6. [DOI] [PubMed] [Google Scholar]
  7. Juvonen R. O., Iwasaki M., Negishi M. Structural function of residue-209 in coumarin 7-hydroxylase (P450coh). Enzyme-kinetic studies and site-directed mutagenesis. J Biol Chem. 1991 Sep 5;266(25):16431–16435. [PubMed] [Google Scholar]
  8. Juvonen R. O., Shkumatov V. M., Lang M. A. Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice. Eur J Biochem. 1988 Jan 15;171(1-2):205–211. doi: 10.1111/j.1432-1033.1988.tb13777.x. [DOI] [PubMed] [Google Scholar]
  9. Järvinen T., Suhonen P., Naumanen H., Urtti A., Peura P. Determination of physicochemical properties, stability in aqueous solutions and serum hydrolysis of pilocarpic acid diesters. J Pharm Biomed Anal. 1991;9(9):737–745. doi: 10.1016/0731-7085(91)80215-u. [DOI] [PubMed] [Google Scholar]
  10. Kimonen T., Juvonen R. O., Alhava E., Pasanen M. The inhibition of CYP enzymes in mouse and human liver by pilocarpine. Br J Pharmacol. 1995 Feb;114(4):832–836. doi: 10.1111/j.1476-5381.1995.tb13279.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lang M. A., Nebert D. W. Structural gene products of the Ah locus. Evidence for many unique P-450-mediated monooxygenase activities reconstituted from 3-methylcholanthrene-treated C57BL/6N mouse liver microsomes. J Biol Chem. 1981 Dec 10;256(23):12058–12067. [PubMed] [Google Scholar]
  12. Lindberg R., Burkhart B., Ichikawa T., Negishi M. The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene. J Biol Chem. 1989 Apr 15;264(11):6465–6471. [PubMed] [Google Scholar]
  13. Miles J. S., McLaren A. W., Forrester L. M., Glancey M. J., Lang M. A., Wolf C. R. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem J. 1990 Apr 15;267(2):365–371. doi: 10.1042/bj2670365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mäenpä J., Sigusch H., Raunio H., Syngelmä T., Vuorela P., Vuorela H., Pelkonen O. Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem Pharmacol. 1993 Mar 9;45(5):1035–1042. doi: 10.1016/0006-2952(93)90247-t. [DOI] [PubMed] [Google Scholar]
  15. Negishi M., Lindberg R., Burkhart B., Ichikawa T., Honkakoski P., Lang M. Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase. Biochemistry. 1989 May 16;28(10):4169–4172. doi: 10.1021/bi00436a007. [DOI] [PubMed] [Google Scholar]
  16. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  17. Pelkonen O., Sotaniemi E. A., Ahokas J. T. Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. Br J Clin Pharmacol. 1985 Jan;19(1):59–66. doi: 10.1111/j.1365-2125.1985.tb02613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Poulos T. L., Finzel B. C., Howard A. J. High-resolution crystal structure of cytochrome P450cam. J Mol Biol. 1987 Jun 5;195(3):687–700. doi: 10.1016/0022-2836(87)90190-2. [DOI] [PubMed] [Google Scholar]
  19. Raag R., Poulos T. L. Crystal structures of cytochrome P-450CAM complexed with camphane, thiocamphor, and adamantane: factors controlling P-450 substrate hydroxylation. Biochemistry. 1991 Mar 12;30(10):2674–2684. doi: 10.1021/bi00224a016. [DOI] [PubMed] [Google Scholar]
  20. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  21. Tsujimoto A., Doi T., Kojima S. Potent inhibitory action of pilocarpine on hepatic drug metabolism. Jpn J Pharmacol. 1972 Oct;22(5):736–739. doi: 10.1254/jjp.22.736. [DOI] [PubMed] [Google Scholar]
  22. Wood A. W., Conney A. H. Genetic variation in coumarin hydroxylase activity in the mouse (Mus musculus). Science. 1974 Aug 16;185(4151):612–614. doi: 10.1126/science.185.4151.612. [DOI] [PubMed] [Google Scholar]
  23. Yamano S., Tatsuno J., Gonzalez F. J. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry. 1990 Feb 6;29(5):1322–1329. doi: 10.1021/bi00457a031. [DOI] [PubMed] [Google Scholar]
  24. Yun C. H., Shimada T., Guengerich F. P. Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol. 1991 Nov;40(5):679–685. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES